comparemela.com

Latest Breaking News On - Frazier life sciences of eyconis inc - Page 1 : comparemela.com

Ascendis Pharma A/S : Form 6-K - MarketScreener

6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K .

New zealandUnited kingdomUnited statesRepublic ofUnited arab emiratesRedwood cityHong kongSaudi arabiaRepublic of chinaTaiwan generalGreat britainSandoz gmbAscendis pharmaMichael wolff jensenBiopartners gmbEli lilly

New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million

COPENHAGEN, Denmark, Jan. 29, 2024 (GLOBE NEWSWIRE) Ascendis Pharma A/S (Nasdaq: ASND) today announced the formation and launch with Frazier Life Sciences of Eyconis, Inc., a separate company created

United statesRedwood cityConrad wangDanna chenEmmett cunninghamDaniel estesAscendis pharmaYvonne yamanakaJan mikkelsenOliver boris stauchFrazier life sciences of eyconis incExchange commissionFrazier life sciencesSenior partnerHealthquest capitalExecutive chairman

vimarsana © 2020. All Rights Reserved.